Copy Link Print Information

Human IgG1 kappa, Isotype Control

20 Cited Publications
Customer Review

Based on 20 publication(s) in Google Scholar

Human IgG1 kappa, Isotype Control is a human monoclonal antibody that is the isotype control of human IgG1 kappa antibody.

For research use only. We do not sell to patients.

  • Purity: 99.71%
  • Molecular Weight:142.68 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Human IgG1 kappa, Isotype Control
  • Experimental Validation Results for Human IgG1 kappa, Isotype Control
  • Experimental Validation Results for Human IgG1 kappa, Isotype Control
  • Experimental Validation Results for Human IgG1 kappa, Isotype Control
  • Experimental Validation Results for Human IgG1 kappa, Isotype Control
  • Experimental Validation Results for Human IgG1 kappa, Isotype Control
  • Experimental Validation Results for Human IgG1 kappa, Isotype Control
  • Human IgG1 kappa, Isotype Control Chemical Structure
    Human IgG1 kappa, Isotype Control Chemical Structure
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Human IgG1 kappa, Isotype Control Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Human IgG1 kappa, Isotype Control

More
Customer Validation & Images
In Vivo Efficacy StudyCell Imaging/StainingCell Proliferation/Viability Assay
  • In Vivo Efficacy Study
  • Cell Proliferation/Viability Assay
  • In Vivo Efficacy Study
  • Cell Imaging/Staining
  • In Vivo Efficacy Study
  • Cell Proliferation/Viability Assay
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Product Image

  • 1/16

    Human IgG1 kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Nat Biotechnol. 2025 Oct 17. [Abstract]

    Customer Validation
     A single mesodermal tumor was injected into mesodermal CAR-T cells, and the following treatments were administered: untreated group, daratumumab (0.5 or 10 μg/ml) treatment group, or IgG isotype control antibody (10 μg/ml IgG) treatment group. The change in T cell area over time was quantitatively analyzed.

  • 1/16

    Human IgG1 kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Front Immunol. 2025 May 21:16:1572676. [Abstract]

    Customer Validation
     Cytotoxicity of NK cells with IgG (10 μg/mL) or anti-PSMA antibody against PCa tissue-derived organoid at E/T ratio of 5:1 after 2 h and 6h coculture measured using LDH assay.

  • 1/16

    Human IgG1 kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: bioRxiv. 2025 Nov 24.

    Customer Validation
     Isotype control antibodies (IgG4κ and IgG1κ) were used as negative controls to demonstrate that pembrolizumab (anti-PD-1) and fragifilimab (anti-GITR) showed no inhibition of tumor growth in the HU-CD34+ T188 PDOX mouse model.

  • 1/16

    Human IgG1 kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Bone Res. 2024 Apr 10;12(1):24. [Abstract]

    Customer Validation
     Representative images display capillary-like structures formed by OPLL-derived ligament cells on Matrigel under distinct conditions : unstimulated (Blank), IgG isotype control (250 μg/ml; 4-6 h), and Bevacizumab .

  • 1/16

    Human IgG1 kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Cancer Lett. 2023 Aug 1:568:216300. [Abstract]

    Customer Validation
     Tumor volumes at various times (horizontal axis) after tumor implantation in the control and treatment groups, including NK, NK + IgG (10 mg/kg; ip), and NK + TIGIT blocker groups.

  • 1/16

    Human IgG1 kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Cancer Lett. 2023 Aug 1:568:216300. [Abstract]

    Customer Validation
     The killing rate of NK cells against C4-2 cells in the NK, NK + IgG (10 μg/ml), NK + vibostolimab, NK + relatlimab and NK + vibostolimab + relatlimab treatment groups was determined using the CCK-8 assay, and the results were obtained after 2 hours and 6 hours of co-culture.

  • Human IgG1 kappa, Isotype Control Chemical Structure
    1/16
  • Human IgG1 kappa, Isotype Control
  • Product Image